1,034
Views
37
CrossRef citations to date
0
Altmetric
Review

CD47 is a Novel Potent Immunotherapy Target in Human Malignancies: Current Studies and Future Promises

&
Pages 2179-2188 | Received 15 Jan 2018, Accepted 20 Mar 2018, Published online: 18 Apr 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Marilyn T Nedumcheril, Robert A DeSimone, Sabrina E Racine-Brzostek, Ok Kyong Chaekal & Ljiljana V Vasovic. (2021) Overcoming Drug Interference in Transfusion Testing: A Spotlight on Daratumumab. Journal of Blood Medicine 12, pages 327-336.
Read now
Hermann AM Mucke. (2021) Patent Highlights December 2020–January 2021. Pharmaceutical Patent Analyst 10:3, pages 103-110.
Read now
Tingpei Ye, Junjiang Liu, Wei Zhao, Shengtao Gao, Shimeng Wang, Fanglong Wu & Hongmei Zhou. (2021) The Hypothesis of Tumor-Associated Macrophages Mediating Semi-Phagocytosis of Cancer Cells in Distant Metastasis. Future Oncology 17:10, pages 1125-1129.
Read now
Daniëlle Verver, Vichnou Poirier-Colame, Gorana Tomasic, Khadija Cherif-Rebai, Dirk J. Grunhagen, Cornelis Verhoef, Stefan Suciu, Caroline Robert, Laurence Zitvogel & Alexander M.M. Eggermont. (2019) Upregulation of intratumoral HLA class I and peritumoral Mx1 in ulcerated melanomas. OncoImmunology 8:11.
Read now
Pranav Murthy, Chigozirim N. Ekeke, Kira L. Russell, Samuel C. Butler, Yue Wang, James D. Luketich, Adam C. Soloff, Rajeev Dhupar & Michael T. Lotze. (2019) Making cold malignant pleural effusions hot: driving novel immunotherapies. OncoImmunology 8:4.
Read now

Articles from other publishers (32)

Marietta Döring, Melanie Brux, Maciej Paszkowski-Rogacz, Pedro M Guillem-Gloria, Frank Buchholz, M Teresa Pisabarro & Mirko Theis. (2024) Nucleolar protein TAAP1/ C22orf46 confers pro-survival signaling in non-small cell lung cancer . Life Science Alliance 7:4, pages e202302257.
Crossref
Martyna Mianowska, Magdalena Zaremba-Czogalla, Adrianna Zygmunt, Mohamed Mahmud, Regine Süss & Jerzy Gubernator. (2023) Dual Role of Vitamin C-Encapsulated Liposomal Berberine in Effective Colon Anticancer Immunotherapy. Pharmaceuticals 17:1, pages 5.
Crossref
Ottavia De Simoni, Luca Dal Santo, Marco Scarpa, Giada Munari, Ylenia Camilla Spolverato, Antonio Scapinello, Sara Lonardi, Caterina Soldà, Francesca Bergamo, Alberto Fantin, Romeo Bardini, Pierluigi Pilati, Matteo Fassan & Mario Gruppo. (2023) Role of Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Could It Be Considered a Predictor of Prognosis?. Current Oncology 30:6, pages 5515-5528.
Crossref
Olamide Tosin Olaoba, Kehinde Sulaimon Ayinde, Olubodun Michael Lateef, Michael Olawale Akintubosun, Khadijat Ayodeji Lawal & Temitope Isaac Adelusi. (2023) Is the new angel better than the old devil? Challenges and opportunities in CD47- SIRPα-based cancer therapy. Critical Reviews in Oncology/Hematology 184, pages 103939.
Crossref
Yu’e Liu, Yanjin Wang, Yanrong Yang, Linjun Weng, Qi Wu, Jin Zhang, Pengcheng Zhao, Lan Fang, Yufeng Shi & Ping Wang. (2023) Emerging phagocytosis checkpoints in cancer immunotherapy. Signal Transduction and Targeted Therapy 8:1.
Crossref
Raúl Muñoz Velasco, Ana García García, Paula Jiménez Sánchez, Inmaculada Montanuy Sellart & Víctor Javier Sánchez-Arévalo Lobo. (2022) Tumour microenvironment and heterotypic interactions in pancreatic cancer. Journal of Physiology and Biochemistry 79:1, pages 179-192.
Crossref
Eslam E. Abd El-Fattah & Hend Mostafa Selim. (2022) Reprograming immune microenvironment modulates CD47 cancer stem cells in hepatocellular carcinoma. International Immunopharmacology 113, pages 109475.
Crossref
Hongyu ZhangPaul A. Dalby. (2022) Stability Convergence in Antibody Coformulations. Molecular Pharmaceutics 19:11, pages 4098-4110.
Crossref
Eunsun Park, Kyung-Hee Song, Darong Kim, Minyoung Lee, Nguyen Van Manh, Hee Kim, Ki Bum Hong, Jeewoo Lee, Jie-Young Song & Soosung Kang. (2022) 2-Amino-1,3,4-thiadiazoles as Glutaminyl Cyclases Inhibitors Increase Phagocytosis through Modification of CD47-SIRPα Checkpoint. ACS Medicinal Chemistry Letters 13:9, pages 1459-1467.
Crossref
Yue Peng, Bin Qiu, Fengwei Tan, Jiachen Xu, Fenglong Bie, Huayu He, Lei Liu, He Tian, Guangyu Bai, Bolun Zhou, Yuan Li, Qilin Huai, Zhenlin Yang & Shugeng Gao. (2022) TIGIT / CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma . Thoracic Cancer 13:14, pages 2014-2023.
Crossref
Çiğdem Sercan, Asuman N. Haberal Reyhan, Özlem Özen & Ali Ayhan. (2022) Clinicopathologic and Prognostic Significance of CD47 Expression and Tumor-associated Macrophages in Endometrial Carcinoma. International Journal of Gynecological Pathology 41:4, pages 397-406.
Crossref
Won Lee, Song Kim, Jae An, Tae-Koon Kim, Hee Cha, Hyo Chang, Sang Kim, Seong Kim & Myung Han. (2022) Tristetraprolin regulates phagocytosis through interaction with CD47 in head and neck cancer. Experimental and Therapeutic Medicine 24:3.
Crossref
Jiangbo Li, Zhijia Sun, Yingshu Cui, Lingmei Qin, Fengyun Wu, Yufang Li, Nan Du & Xiaosong Li. (2022) Knockdown of LMNB1 Inhibits the Proliferation of Lung Adenocarcinoma Cells by Inducing DNA Damage and Cell Senescence. Frontiers in Oncology 12.
Crossref
Jimena Álvarez Freile, Natasha Ustyanovska Avtenyuk, Macarena González Corrales, Harm Jan Lourens, Gerwin Huls, Tom van Meerten, Ewa Cendrowicz & Edwin Bremer. (2022) CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma. Biomedicines 10:5, pages 1175.
Crossref
Zu-Chian Chiang, Shubin Fang, Yang-kun Shen, Dongya Cui, Huanjiao Weng, Dawei Wang, Yuxiang Zhao, Jizhen Lin & Qi Chen. (2022) Development of Novel CD47-Specific ADCs Possessing High Potency Against Non-Small Cell Lung Cancer in vitro and in vivo. Frontiers in Oncology 12.
Crossref
Xiaobao Yang, Jinrong Lin, Guanzheng Wang & Dakang Xu. (2022) Targeting Proliferating Tumor-Infiltrating Macrophages Facilitates Spatial Redistribution of CD8+ T Cells in Pancreatic Cancer. Cancers 14:6, pages 1474.
Crossref
Katrin Pansy, Barbara Uhl, Jelena Krstic, Marta Szmyra, Karoline Fechter, Ana Santiso, Lea Thüminger, Hildegard Greinix, Julia Kargl, Katharina Prochazka, Julia Feichtinger & Alexander JA. Deutsch. (2021) Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions. International Journal of Molecular Sciences 22:24, pages 13311.
Crossref
Janney Z. Wang, Vivian Lin, Elsa Toumi, Ke Wang, Hong Zhu, R. Max Conway, Michele C. Madigan, Michael Murray, Svetlana Cherepanoff, Fanfan Zhou & Wenying Shu. (2021) Development of new therapeutic options for the treatment of uveal melanoma. The FEBS Journal 288:21, pages 6226-6249.
Crossref
Zhenlin Yang, Yue Peng, Wei Guo, Jiachen Xu, Lin Li, He Tian, Renda Li, Lei Liu, Fengwei Tan, Shugeng Gao & Jie He. (2021) PD‐L1 and CD47 co‐expression predicts survival and enlightens future dual‐targeting immunotherapy in non‐small cell lung cancer . Thoracic Cancer 12:11, pages 1743-1751.
Crossref
Rebeca Gonzalez-Pastor, Peter S. Goedegebuure & David T. Curiel. (2020) Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer. Cancer Gene Therapy 28:5, pages 375-389.
Crossref
Hyunsung Kim, Seungyun Jee, Yeseul Kim, Jongmin Sim, Seongsik Bang, Hwang Kyu Son, Hosub Park, Jaekyung Myung, Young Hyeh Ko & Seung Sam Paik. (2021) Correlation of CD47 Expression with Adverse Clinicopathologic Features and an Unfavorable Prognosis in Colorectal Adenocarcinoma. Diagnostics 11:4, pages 668.
Crossref
Julian A. Marin-Acevedo, ErinMarie O. Kimbrough & Yanyan Lou. (2021) Next generation of immune checkpoint inhibitors and beyond. Journal of Hematology & Oncology 14:1.
Crossref
Helmut PopperHelmut Popper. 2021. Pathology of Lung Disease. Pathology of Lung Disease 353 596 .
Jinyang Hu, Qungen Xiao, Minhai Dong, Dongsheng Guo, Xudong Wu & Baofeng Wang. (2020) Glioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis. Frontiers in Immunology 11.
Crossref
Antonia Busse, Liliana H. Mochmann, Christiane Spenke, Ruza Arsenic, Franziska Briest, Korinna Jöhrens, Hedwig Lammert, Bence Sipos, Anja A. Kühl, Ralph Wirtz, Marianne Pavel, Michael Hummel, Daniel Kaemmerer, Richard P. Baum & Patricia Grabowski. (2020) Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment. Cancers 12:11, pages 3448.
Crossref
Yun Liu, Yue Chang, Xinhong He, Yixuan Cai, Hao Jiang, Ru Jia & Jiyan Leng. (2020) CD47 Enhances Cell Viability and Migration Ability but Inhibits Apoptosis in Endometrial Carcinoma Cells via the PI3K/Akt/mTOR Signaling Pathway. Frontiers in Oncology 10.
Crossref
Oscar Arrieta, Alejandro Aviles‐Salas, Mario Orozco‐Morales, Norma Hernández‐Pedro, Andrés F. Cardona, Luis Cabrera‐Miranda, Pedro Barrios‐Bernal, Giovanny Soca‐Chafre, Graciela Cruz‐Rico, María de Lourdes Peña‐Torres, Guadalupe Moncada‐Claudio & Laura‐Alejandra Ramirez‐Tirado. (2020) Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non‐small cell lung cancer. Cancer Medicine 9:7, pages 2390-2402.
Crossref
Zijun Zhao, Xiaoyun Xiao, Phei Er Saw, Wei Wu, Hongyan Huang, Jiewen Chen & Yan Nie. (2019) Chimeric antigen receptor T cells in solid tumors: a war against the tumor microenvironment. Science China Life Sciences 63:2, pages 180-205.
Crossref
Chiu-Lin Wang, Ming-Jie Lin, Chia-Yi Hsu, Hsiao-Yun Lin, Hung-Pei Tsai, Cheng-Yu Long, Eing-Mei Tsai, Tsung-Hua Hsieh & Chin-Hu Wu. (2019) CD47 promotes cell growth and motility in epithelial ovarian cancer. Biomedicine & Pharmacotherapy 119, pages 109105.
Crossref
Isao Otsuka. (2019) Cutaneous Metastasis after Surgery, Injury, Lymphadenopathy, and Peritonitis: Possible Mechanisms. International Journal of Molecular Sciences 20:13, pages 3286.
Crossref
Melissa M. Cushing, Robert A. DeSimone, Ruchika Goel, Yen‐Michael S. Hsu, Priscilla Parra, Sabrina E. Racine‐Brzostek, Diana Degtyaryova, Dian T. Lo, Meta Morrison, Kathleen M. Crowley, Adrianna Rossi & Ljiljana V. Vasovic. (2019) The impact of Daratumumab on transfusion service costs. Transfusion 59:4, pages 1252-1258.
Crossref
K.M. Byrne, C.M.C. Mercado, T.N. Nnabue, T.D. Paige & W.A. Flegel. (2019) Inhibition of blood group antibodies by soluble substances. Immunohematology 35:1, pages 19-22.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.